BioFuels Journal

Evry, France, Jan. 21, 2016 - Global Bioenergies (Alternext Paris: ALGBE) (the "Company") today announces the successful completion of a private placement with qualified French and international investors.

The Company placed 274,931 new shares at a par value of [Eur]0.05 per share, at a unit price of [Eur]23.70, including share premium, for a total of approximately [Eur]6.5 million amounting to 9.6% of the Company's share capital.

For information, the stake of a shareholder with 1% of the Company's share capital prior to the issue will be brought to 0.91%.

The proceeds will be used to further the development of the Isobutene process and to launch commercial roll-out.

Marc Delcourt, CEO at Global Bioenergies says: "The success of this transaction demonstrates investors' confidence in our corporate strategy.

"The proceeds of the placement increase the Company's unaudited cash to 16.5 million euros.

"They will enable the Company to fully transition into the commercial phase."

The principle of the capital raising was authorized on 5 January 2016.

The transaction was carried out pursuant to a Board decisions dated 20 January 2016 and 21 January 2016, in accordance with the authority granted to it by the eighth resolution of the Combined General Meeting of Shareholders on 3 June 2015.

The subscription price represented a discount of 14.1% over the volume weighted average Company's share price in the last three trading sessions prior to the issue.

The capital increase is by means of the issue of common shares without preferential subscription rights to qualified investors, in accordance with Article L. 411-2 II of the French Monetary and Financial Code (Code monetaire et financier).

The new shares will carry entitlement to dividend rights and will be admitted to trading on the Euronext Paris Alternext market under ISIN code FR0011052257 - ALGBE.

On settlement and delivery of the shares, Company's share capital will comprise 3,145,128 shares.

The Private Placement is conducted by Gilbert Dupont (Paris) and Baader Bank AG (Munich) as joint lead managers and joint bookrunners.

The issue does not require registration with the French financial markets authority (AMF) or publication of a prospectus.

For more information, please contact [email protected].

See Related Websites/Articles:

• Global Bioenergies

more ADVANCED BIOFUELS...